Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Vaica to Offer Anticoagulation Medication Adherence & Monitoring solution
  • USA - English


News provided by

Vaica Medical

19 Apr, 2021, 19:28 IDT

Share this article

Share toX

Share this article

Share toX

TEL AVIV, Israel, April 19, 2021 /PRNewswire/ -- Vaica™ Medical, an innovation leading provider in medication adherence and remote patient management (RPM) is announcing its anti-coagulation (blood clotting) remote management solution.

Continue Reading
The Vaica Medy(TM) provides a seamless workflow for monitoring vital signs as well as medication adherence for patients from the comfort of their own home
The Vaica Medy(TM) provides a seamless workflow for monitoring vital signs as well as medication adherence for patients from the comfort of their own home

The need to maintain an optimal blood viscosity levels is pertinent for at-risk patients with Thrombotic Predisposition (hypercoagulable states), heart rhythm disorders, artificial heart valves, Renal failure, and more.  In the US alone, 1% of the adult population are on blood thinners.  A commonly prescribed (and affordable) medication is Warfarin. However, the use of Warfarin requires life-long and frequent blood testing of INR (blood-thinning level) to optimize the dosage and ensure that the INR remains within the patient-specific therapeutic range. This current standard of care requires frequent laboratory and doctor visits, which in many cases deters patients and cause them not to adhere to their treatment regimen– a life-threatening situation.

Vaica's comprehensive 360◦ "Track and Treat" approach provides all necessary tools to successfully address these challenges. The basic Anticoagulation kit includes Vaica's SimpleMed™ Smart Medication adherence dispenser, along with a home Coagulometer.  Patients will be reminded daily to take their medication, and periodically to measure their INR. The physician shall receive all the information necessary to resolve of out-of-therapeutic-range results. This unique platform will markedly reduce the need for patients' laboratory and doctor office visits, and most importantly, will ensure that patients remain within their target therapeutic range, thus minimizing the risks of life-threatening hemorrhagic or thromboembolic complications.

"Vaica's seamless solution, far exceeding today's standard-of-care, provides an effective means to successfully tackle a serious problem," said Eran Steinberg, Vaica's President. "Smart management of blood thinning is yet another consequential and innovative offering from Vaica"

The data generated by Vaica`s Anticoagulation Kit, integrating electronic medication dispenser for optimizing Warfarin adherence with home coagulometer, is seamlessly aggregated by the Medy™ home hub and uploaded via cellular connectivity to the secure Vaica cloud infrastructure.  The entire workflow is reimbursable by the major US insurance agencies using existing CPT codes.

For more Information, please refer to https://www.vaica.com/medy-rpm/

About Vaica

Vaica™ Medical  (www.vaica.com) is a leading Telemedicine Company positioned in the nexus of Remote Patient Monitoring Platform (RPM) coupled with Smart Medication Adherence IoT Devices for increasing patient engagement, persistence and well-being.

Company Contact:

Noa Lapidot 
Business Unit Director 
[email protected]

Photo - https://mma.prnewswire.com/media/1490795/Vaica_Medical.jpg

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.